Gender medicine and oncology: report and consensus of an ESMO workshop
Open accessThe DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
BACKGROUND The importance of sex and gender as modulators of disease biology and treatment outcomes is well known in other disciplines of medicine, such as cardiology, but remains an undervalued issue in oncology. Considering the increasing evidence for their relevance, ESMO decided to address this topic and organized a multidisciplinary workshop in Lausanne, Switzerland, on November 30th and December 1st, 2018. DESIGN 20 invited faculty members and 40 selected physicians/scientists participated. Relevant content was presented by faculty members on the basis of a literature review conducted by each speaker. Following a moderated consensus session, the final consensus statements are reported here. RESULTS Clinically relevant sex differences include tumor biology, immune system activity, body composition and drug disposition and effects. The main differences between male and female cells are sex chromosomes and the level of sexual hormones they are exposed to. They influence both local and systemic determinants of carcinogenesis. Their effect on carcinogenesis in non-reproductive organs is largely unknown. Recent evidence also suggests differences in tumor biology and molecular markers. Regarding body composition, the difference in metabolically active, fat-free body mass is one of the most prominent: in a man and a woman of equal weight and height, it accounts for 80% of the man's and 65% of the woman's body mass, and is not taken into account in body-surface area based dosing of chemotherapy. CONCLUSION Sex differences in cancer biology and treatment deserve more attention and systematic investigation. Interventional clinical trials evaluating sex-specific dosing regimens are necessary to improve the balance between efficacy and toxicity for drugs with significant pharmacokinetic differences. Especially in diseases or disease subgroups with significant differences in epidemiology or outcomes, men and women with non-sex related cancers should be considered as biologically distinct groups of patients, for whom specific treatment approaches merit consideration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Comprehensive molecular characterization of gastric adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13480 · Cited by 6,498
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
Estimating glomerular filtration rate from serum creatinine and cystatin C
Inker, L. A., Schmid, C. H., Tighiouart, H., Eckfeldt, J. H., Feldman, H. I., Greene, T., Kusek, J. W., Manzi, J., Van Lente, F., Zhang, Y. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114248 · Cited by 4,102
Ferlay, J., Colombet, M., Soerjomataram, I., Dyba, T., Randi, G., Bettio, M., Gavin, A., Visser, O., & Bray, F. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.07.005 · Cited by 2,478
Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity
Markle, J. G. M., Frank, D. N., Mortin-Toth, S., Robertson, C. E., Feazel, L. M., Rolle-Kampczyk, U., von Bergen, M., McCoy, K. D., Macpherson, A. J., & Danska, J. S. (2013) · Science · doi:10.1126/science.1233521 · Cited by 2,025
Policy: NIH to balance sex in cell and animal studies
Clayton, J. A., & Collins, F. S. (2014) · Nature · doi:10.1038/509282a · Cited by 1,816
A Prognostic Score for Advanced Hodgkin's Disease
Hasenclever, D., Diehl, V., Armitage, J. O., Assouline, D., Björkholm, M., Brusamolino, E., Canellos, G. P., Carde, P., Crowther, D., Cunningham, D., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392104 · Cited by 1,736
Shen, W., Punyanitya, M., Wang, Z., Gallagher, D., St.-Onge, M.-P., Albu, J., Heymsfield, S. B., & Heshka, S. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00744.2004 · Cited by 1,692
The microbiome, cancer, and cancer therapy
Helmink, B. A., Khan, M. A. W., Hermann, A., Gopalakrishnan, V., & Wargo, J. A. (2019) · Nature Medicine · doi:10.1038/s41591-019-0377-7 · Cited by 1,200
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
Conforti, F., Pala, L., Bagnardi, V., De Pas, T., Martinetti, M., Viale, G., Gelber, R. D., & Goldhirsch, A. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30261-4 · Cited by 973
Quantification of Lean Bodyweight
Janmahasatian, S., Duffull, S. B., Ash, S., Ward, L. C., Byrne, N. M., & Green, B. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544100-00004 · Cited by 900
Genders, sexes, and health: what are the connections—and why does it matter?
Krieger, N. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg156 · Cited by 788
The X chromosome in immune functions: when a chromosome makes the difference
Libert, C., Dejager, L., & Pinheiro, I. (2010) · Nature Reviews Immunology · doi:10.1038/nri2815 · Cited by 781
Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes
(2016) · European Heart Journal · doi:10.1093/eurheartj/ehv598 · Cited by 739
Intestinal Microbiota Is Influenced by Gender and Body Mass Index
Haro, C., Rangel-Zúñiga, O. A., Alcalá-Díaz, J. F., Gómez-Delgado, F., Pérez-Martínez, P., Delgado-Lista, J., Quintana-Navarro, G. M., Landa, B. B., Navas-Cortés, J. A., Tena-Sempere, M., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154090 · Cited by 671
TLR7 escapes X chromosome inactivation in immune cells
Souyris, M., Cenac, C., Azar, P., Daviaud, D., Canivet, A., Grunenwald, S., Pienkowski, C., Chaumeil, J., Mejía, J. E., & Guéry, J.-C. (2018) · Science Immunology · doi:10.1126/sciimmunol.aap8855 · Cited by 641
Sex differences in gut microbiota
Kim, Y. S., Unno, T., Kim, B.-Y., & Park, M.-S. (2020) · The World Journal of Men s Health · doi:10.5534/wjmh.190009 · Cited by 610
Sex and gender differences in health: Science & Society Series on Sex and Science
Regitz‐Zagrosek, V. (2012) · The EMBO Reports · doi:10.1038/embor.2012.87 · Cited by 572
The Epidemiology of Esophageal Adenocarcinoma
Coleman, H. G., Xie, S.-H., & Lagergren, J. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.07.046 · Cited by 549
Sex Differences in Pharmacokinetics and Pharmacodynamics
Gandhi, M., Aweeka, F., Greenblatt, R. M., & Blaschke, T. F. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121453 · Cited by 542
Ostermann, S., Csajka, C., Buclin, T., Leyvraz, S., Lejeune, F., Decosterd, L. A., & Stupp, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0807 · Cited by 518
Self-citationThe Challenge of Subgroup Analyses — Reporting without Distorting
Lagakos, S. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068070 · Cited by 504
Gender differences in drug responses
FRANCONI, F., BRUNELLESCHI, S., STEARDO, L., & CUOMO, V (2007) · Pharmacological Research · doi:10.1016/j.phrs.2006.11.001 · Cited by 454
Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias
Dunford, A., Weinstock, D. M., Savova, V., Schumacher, S. E., Cleary, J. P., Yoda, A., Sullivan, T. J., Hess, J. M., Gimelbrant, A. A., Beroukhim, R., et al. (2017) · Nature Genetics · doi:10.1038/ng.3726 · Cited by 453
Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years
Duma, N., Vera Aguilera, J., Paludo, J., Haddox, C. L., Gonzalez Velez, M., Wang, Y., Leventakos, K., Hubbard, J. M., Mansfield, A. S., Go, R. S., et al. (2018) · Journal of Oncology Practice · doi:10.1200/jop.2017.025288 · Cited by 446
Self-citationWhite, A., Ironmonger, L., Steele, R. J. C., Ormiston-Smith, N., Crawford, C., & Seims, A. (2018) · BMC Cancer · doi:10.1186/s12885-018-4786-7 · Cited by 405
Schwab, M., Zanger, U. M., Marx, C., Schaeffeler, E., Klein, K., Dippon, J., Kerb, R., Blievernicht, J., Fischer, J., Hofmann, U., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.4182 · Cited by 393
Symptom Presentation of Women With Acute Coronary Syndromes: Myth vs Reality
Canto, J. G. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.22.2405 · Cited by 376
Clocchiatti, A., Cora, E., Zhang, Y., & Dotto, G. P. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.30 · Cited by 374
Self-citationRate of Growth in Melanomas: Characteristics and Associations of Rapidly Growing Melanomas
Liu, W., Dowling, J. P., Murray, W. K., McArthur, G. A., Thompson, J. F., Wolfe, R., & Kelly, J. W. (2006) · Archives of Dermatology · doi:10.1001/archderm.142.12.1551 · Cited by 353
Lemmens, V. E., Klaver, Y. L., Verwaal, V. J., Rutten, H. J., Coebergh, J. W. W., & de Hingh, I. H. (2011) · International Journal of Cancer · doi:10.1002/ijc.25596 · Cited by 352
Self-citationGamelin, E., Delva, R., Jacob, J., Merrouche, Y., Raoul, J. L., Pezet, D., Dorval, E., Piot, G., Morel, A., & Boisdron-Celle, M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.3934 · Cited by 346
Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients
Yuan, Y., Liu, L., Chen, H., Wang, Y., Xu, Y., Mao, H., Li, J., Mills, G. B., Shu, Y., Li, L., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.001 · Cited by 331
Gender differences in the effects of cardiovascular drugs
Tamargo, J., Rosano, G., Walther, T., Duarte, J., Niessner, A., Kaski, J., Ceconi, C., Drexel, H., Kjeldsen, K., Savarese, G., et al. (2017) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvw042 · Cited by 317
Polom, K., Marano, L., Marrelli, D., De Luca, R., Roviello, G., Savelli, V, Tan, P., & Roviello, F. (2018) · Journal of British Surgery · doi:10.1002/bjs.10663 · Cited by 292
Wallis, C. J. D., Butaney, M., Satkunasivam, R., Freedland, S. J., Patel, S. P., Hamid, O., Pal, S. K., & Klaassen, Z. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.5904 · Cited by 290
The Mouse Microbiome Is Required for Sex-Specific Diurnal Rhythms of Gene Expression and Metabolism
Weger, B. D., Gobet, C., Yeung, J., Martin, E., Jimenez, S., Betrisey, B., Foata, F., Berger, B., Balvay, A., Foussier, A., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.023 · Cited by 269
Gender Differences in Melanoma Survival: Female Patients Have a Decreased Risk of Metastasis
Joosse, A., de Vries, E., Eckel, R., Nijsten, T., Eggermont, A. M. M., Hölzel, D., Coebergh, J. W. W., & Engel, J. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.354 · Cited by 266
The Current State of Knowledge on Age, Sex, and Their Interactions on Clinical Pharmacology
Schwartz, J. B. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100226 · Cited by 256
How to calculate the dose of chemotherapy
Gurney, H. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600139 · Cited by 251
Müller, C., Murawski, N., Wiesen, M. H. J., Held, G., Poeschel, V., Zeynalova, S., Wenger, M., Nickenig, C., Peter, N., Lengfelder, E., et al. (2012) · Blood · doi:10.1182/blood-2011-09-380949 · Cited by 242
McPherson, S. J., Hussain, S., Balanathan, P., Hedwards, S. L., Niranjan, B., Grant, M., Chandrasiri, U. P., Toivanen, R., Wang, Y., Taylor, R. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905524107 · Cited by 197
Excess body fat in obese and normal-weight subjects
Thomas, E. L., Frost, G., Taylor-Robinson, S. D., & Bell, J. D. (2012) · Nutrition Research Reviews · doi:10.1017/s0954422412000054 · Cited by 196
Joosse, A., Collette, S., Suciu, S., Nijsten, T., Patel, P. M., Keilholz, U., Eggermont, A. M. M., Coebergh, J. W. W., & de Vries, E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.5031 · Cited by 192
Cho, S. Y., Park, J. W., Liu, Y., Park, Y. S., Kim, J. H., Yang, H. P., Um, H., Ko, W. R., Lee, B. I., Kwon, S. Y., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.05.012 · Cited by 175
Systemic Stromal Effects of Estrogen Promote the Growth of Estrogen Receptor–Negative Cancers
Gupta, P. B., Proia, D., Cingoz, O., Weremowicz, J., Naber, S. P., Weinberg, R. A., & Kuperwasser, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3895 · Cited by 175
de Vries, E., Nijsten, T. E. C., Visser, O. J., Bastiaannet, E., van Hattem, S., Janssen-Heijnen, M. L. G., & Coebergh, J. W. W. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm498 · Cited by 173
Sex Differences in Cancer Driver Genes and Biomarkers
Li, C. H., Haider, S., Shiah, Y.-J., Thai, K., & Boutros, P. C. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0362 · Cited by 161
Özdemir, B. C., Csajka, C., Dotto, G. P., & Wagner, D. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.3290 · Cited by 153
Self-citationMcCune, J. S., Bemer, M. J., Barrett, J. S., Baker, K. S., Gamis, A. S., & Holford, N. H. G. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1960 · Cited by 148
Sex and Gender Aspects in Clinical Medicine
Franconi, F., Straface, E., Chessa, R., Rosano, G., & Sanna, M. (2011) · Springer eBooks · doi:10.1007/978-0-85729-832-4 · Cited by 144
Junlén, H. R., Peterson, S., Kimby, E. K., Lockmer, S., Lindén, O., Nilsson‐Ehle, H., Erlanson, M., Hagberg, H., Rådlund, A., Hagberg, O., et al. (2014) · Leukemia · doi:10.1038/leu.2014.251 · Cited by 144
Suboptimal dosing of rituximab in male and female patients with DLBCL
Pfreundschuh, M. G., Müller, C., Zeynalova, S., Kuhnt, E., Wiesen, M. H. J., Held, G., Rixecker, T., Poeschel, V., Zwick, C., Reiser, M., et al. (2013) · Blood · doi:10.1182/blood-2013-07-517037 · Cited by 144
Allometric size: The scientific theory and extension to normal fat mass
Holford, N. H. G., & Anderson, B. J. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.05.056 · Cited by 137
Beumer, J. H., Chu, E., Allegra, C. J., Tanigawara, Y., Milano, G. A., Diasio, R. B., Kim, T. W., Mathijssen, R. H. J., Zhang, L., Arnold, D., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1124 · Cited by 134
Sex and gender influences on pharmacological response: an overview
Franconi, F., & Campesi, I. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.922866 · Cited by 132
Steffen, A., Schulze, M. B., Pischon, T., Dietrich, T., Molina, E., Chirlaque, M.-D., Barricarte, A., Amiano, P., Quirós, J. R., Tumino, R., et al. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0265 · Cited by 127
Dosage compensation of the sex chromosomes and autosomes
Disteche, C. M. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2016.04.013 · Cited by 124
Mueller, F., Büchel, B., Köberle, D., Schürch, S., Pfister, B., Krähenbühl, S., Froehlich, T. K., Largiadèr, C. R., & Joerger, M. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-2018-4 · Cited by 117
Sex disparity in cancer: roles of microRNAs and related functional players
Carè, A., Bellenghi, M., Matarrese, P., Gabriele, L., Salvioli, S., & Malorni, W. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-017-0051-x · Cited by 116
The Male Predominance in Esophageal Adenocarcinoma
Xie, S., & Lagergren, J. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.10.005 · Cited by 116
Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy
Capone, I., Marchetti, P., Ascierto, P. A., Malorni, W., & Gabriele, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00552 · Cited by 114
Burkhardt, B., Oschlies, I., Klapper, W., Zimmermann, M., Woessmann, W., Meinhardt, A., Landmann, E., Attarbaschi, A., Niggli, F. K., Schrappe, M., et al. (2010) · Leukemia · doi:10.1038/leu.2010.245 · Cited by 108
Gender difference in gastro-esophageal reflux diseases
Asanuma, K., Iijima, K., & Shimosegawa, T. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i5.1800 · Cited by 101
Gender differences in clinical registration trials: is there a real problem?
Labots, G., Jones, A., de Visser, S. J., Rissmann, R., & Burggraaf, J. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13497 · Cited by 94
Population Pharmacokinetic Analysis of Panitumumab in Patients With Advanced Solid Tumors
Ma, P., Yang, B., Wang, Y., Peterson, M., Narayanan, A., Sutjandra, L., Rodriguez, R., & Chow, A. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009344989 · Cited by 89
Superior Survival of Young Women with Malignant Melanoma
Kemeny, M. M., Busch, E., Stewart, A. K., & Menck, H. R. (1998) · The American Journal of Surgery · doi:10.1016/s0002-9610(98)00070-1 · Cited by 88
Klein, C. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.129502 · Cited by 83
Population pharmacokinetics of bevacizumab in cancer patients with external validation
Han, K., Peyret, T., Marchand, M., Quartino, A. L., Gosselin, N. H., Girish, S., Allison, D. E., & Jin, J. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3079-6 · Cited by 80
Bressolle, F., Joulia, J. M., Pinguet, F., Ychou, M., Astre, C., Duffour, J., & Goméni, R. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050980 · Cited by 79
Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation
Clocchiatti, A., Ghosh, S., Procopio, M.-G., Mazzeo, L., Bordignon, P., Ostano, P., Goruppi, S., Bottoni, G., Katarkar, A., Levesque, M. P., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99159 · Cited by 74
Self-citationMultifactorial ERβ and NOTCH1 control of squamous differentiation and cancer
Brooks, Y., Ostano, P., Jo, S. H., Dai, J., Getsios, S., Dziunycz, P., Hofbauer, G. F. L., Cerveny, K. L., Chiorino, G., Lefort, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72718 · Cited by 71
Self-citationMonnereau, A., Troussard, X., Belot, A., Guizard, A., Woronoff, A., Bara, S., Lapôtre‐Ledoux, B., Iwaz, J., Trétarre, B., Maynadié, M., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27889 · Cited by 70
Petrick, J. L., Hyland, P. L., Caron, P., Falk, R. T., Pfeiffer, R. M., Dawsey, S. M., Abnet, C. C., Taylor, P. R., Weinstein, S. J., Albanes, D., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy082 · Cited by 69
Nguyen, G. K., Mellnick, V. M., Yim, A. K., Salter, A. R., & Ippolito, J. E. (2018) · Radiology · doi:10.1148/radiol.2018171504 · Cited by 66
Investigation of female survival benefit in metastatic melanoma
Richardson, B., Price, A., Wagner, M., Williams, V, Lorigan, P., Browne, S., Miller, J. G., & Neil, S. M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690637 · Cited by 62
Rožman, S., Grabnar, I., Novaković, S., Mrhar, A., & Novaković, B. J. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13271 · Cited by 58
Inhibition of lymphoma vascularization and dissemination by estrogen receptor β agonists
Yakimchuk, K., Hasni, M. S., Guan, J., Chao, M. P., Sander, B., & Okret, S. (2014) · Blood · doi:10.1182/blood-2013-07-517292 · Cited by 57
Joerger, M., Kraff, S., Huitema, A. D. R., Feiss, G. L., Moritz, B., Schellens, J. H. M., Beijnen, J. H., & Jaehde, U. (2012) · Clinical Pharmacokinetics · doi:10.1007/bf03261934 · Cited by 56
Optimization of rituximab for the treatment of DLBCL : increasing the dose for elderly male patients
Pfreundschuh, M. G., Murawski, N., Zeynalova, S., Ziepert, M., Loeffler, M., Hänel, M., Dierlamm, J., Keller, U. B., Dreyling, M. H., Trümper, L. H. P., et al. (2017) · British Journal of Haematology · doi:10.1111/bjh.14860 · Cited by 56
Modest, D. P., von Weikersthal, L. F., Decker, T. W., Vehling‐Kaiser, U., Uhlig, J., Schenk, M., Freiberg‐Richter, J., Peuser, B., Denzlinger, C., Reddemann, C. P. G., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.18.00052 · Cited by 55
Meric‐Bernstam, F., Lee, R. J., Carthon, B. C., Iliopoulos, O., Mier, J. W., Patel, M. R., Tannir, N. M., Owonikoko, T. K., Haas, N. B., Voss, M. H., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2019.37.7_suppl.549 · Cited by 53
Han, K., Jin, J., Maia, M., Lowe, J. A., III, Sersch, M. A., & Allison, D. E. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9631-6 · Cited by 49
Petrick, J. L., Falk, R. T., Hyland, P. L., Caron, P., Pfeiffer, R. M., Wood, S. N., Dawsey, S. M., Abnet, C. C., Taylor, P. R., Guillemette, C., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190325 · Cited by 44
Hing, J. P., Ruixo, J. J. P., Stuyckens, K., Soto-Matos, A., Lázaro, L. L., & Zannikos, P. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100259 · Cited by 41
Age and Sex in Non-Hodgkin Lymphoma Therapy: It’s Not All Created Equal, or Is It?
Pfreundschuh, M. G. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175447 · Cited by 37
Mougenot, P., Pinguet, F., Fabbro, M., Culine, S., Poujol, S., Astre, C., & Bressolle, F. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0761-2 · Cited by 33
Berg, A. K., Buckner, J. C., Galanis, E., Jaeckle, K. A., Ames, M. M., & Reid, J. M. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.543 · Cited by 26
Sexual Inequality in the Cancer Cell
Arnold, A. P., & Distèche, C. M. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-2219 · Cited by 26
Boriani, G., Lorenzetti, S., Cerbai, E., Oreto, G., Bronzetti, G., Malavasi, V. L., Biffi, A., Padeletti, L., Botto, G., & Diemberger, I. (2017) · EP Europace · doi:10.1093/europace/eux068 · Cited by 23
Beheshti, A., Neuberg, D. S., McDonald, J. T., Vanderburg, C. R., & Evens, A. M. (2015) · Cancer Informatics · doi:10.4137/cin.s34144 · Cited by 21
Predicting the Efficacy of an Oral Paclitaxel Formulation (DHP107) Through Modeling and Simulation
Lim, H., Bae, K., Jung, J., Noh, Y.-H., Hwang, A.-K., Jo, Y.-W., Hong, Y. S., Kim, K., Lee, J., Park, S., et al. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.12.009 · Cited by 20
Eggermont, A. M. M., Kicinski, M., Blank, C. U., Mandalà, M., Long, G. V., Atkinson, V., Dalle, S., Haydon, A. M., Lichinitser, M., Khattak, M., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2019.37.15_suppl.2517 · Cited by 14
Thai, H., Veyrat‐Follet, C., Mentré, F., & Comets, E. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2182-1 · Cited by 14
Wagner, D., Özdemir, B. C., & Csajka, C. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.18.01668 · Cited by 3
Self-citation
Cited by
Sex and gender: modifiers of health, disease, and medicine
Mauvais-Jarvis, F., Bairey Merz, N., Barnes, P. J., Brinton, R. D., Carrero, J.-J., DeMeo, D. L., De Vries, G. J., Epperson, C. N., Govindan, R., Klein, S. L., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31561-0 · Cited by 2,001
Sex disparities matter in cancer development and therapy
Haupt, S., Caramia, F., Klein, S. L., Rubin, J. B., & Haupt, Y. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00348-y · Cited by 331
Metadata
- Authors
- Wagner, A. D., Oertelt-Prigione, S., Adjei, A., Buclin, T., Cristina, V., Csajka, C., Coukos, G., Dafni, U., Dotto, G.-P., Ducreux, M., Fellay, J., Haanen, J., Hocquelet, A., Klinge, I., Lemmens, V., Letsch, A., Mauer, M., Moehler, M., Peters, S., & Özdemir, B. C.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2019-12
- Volume
- 30
- Issue
- 12
- Pages
- 1914-1924
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2980659545
- Cited by
- 214
- References
- 98
- FWCI
- 18.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.